INTRODUCTION
============

Sweet\'s syndrome is characterized by clinical symptoms, pathologic findings which include fever, neutrophilia, tender erythematous skin lesions, and predominantly neutrophilic infiltration in the dermis \[[@B1]\]. Sweet\'s syndrome can be subdivided into three main forms: classical (or idiopathic), malignancy associated, and drug-induced Sweet\'s syndrome \[[@B2]\]. Recently, a \"histiocytoid\" pathologic variant of Sweet\'s syndrome has been described, and has been named histiocytoid Sweet\'s syndrome \[[@B3]\]. There are several disorders whose dermatologic symptoms can morphologically mimic those of Sweet\'s syndrome. We present a confusing case in which the patient initially appeared to have parotitis but turned out to have histiocytoid Sweet\'s syndrome.

CASE
====

A 57-year-old man reported swelling and tenderness on his right cheek for two months ([Fig. 1](#F1){ref-type="fig"}). There was a history of upper respiratory tract infection two weeks earlier. We assumed that parotitis was caused by obstruction of the parotid duct, but outpatient treatment with oral antibiotics did not result in improvement. Furthermore, right sialography revealed no obstruction signs and no mass lesions ([Fig. 2](#F2){ref-type="fig"}). During outpatient follow-up, erythematous papules and plaques started to appear on his hand and periocular regions ([Fig. 3](#F3){ref-type="fig"}). Laboratory studies showed normal levels of neutrophils, except for an increased level of C-reactive protein (3.77 mg/dL) and erythrocyte sedimentation rate (95 mm/hr). We suspected autoimmune disease, and thus a skin punch biopsy was performed on the dorsum plaque of the right hand. Histopathologically, superficial perivenular histiocytic infiltration without vasculitis and nuclear debri admixed with papillary edema were seen in erythematous papules on the dorsum of the right hand ([Fig. 4](#F4){ref-type="fig"}). After the histopathological and clinical diagnosis of Sweet\'s syndrome was made, systemic methylprednisolone was administered, starting with 32 mg per day, for 2 weeks. The dose was tapered to 4 mg over the course of the next 2 weeks. He responded with healing of the cutaneous lesions and of cheek swelling within a few days from the beginning of therapy.

DISCUSSION
==========

Sweet\'s syndrome was originally described by Dr. Sweet \[[@B1]\] in 1964. It is characterized by fever, neutrophilia, tender erythematous skin lesions, and histopathologic evidence of a dense neutrophilic infiltration on the papillary dermis without vasculitis \[[@B1]\]. Sweet\'s syndrome has a worldwide distribution and no racial predilection. An annual incidence of 2.7 cases per 10^6^ population was estimated in Scotland \[[@B4]\]. The disease can occur in patients of any age. The female sex predominates, with a ratio of 3.7:1 \[[@B5]\]. Reported data about the incidence and prevalence of Sweet\'s syndrome in Korea does not exist.

The diagnostic criteria for Sweet\'s syndrome were first proposed by Su and Liu \[[@B6]\] in 1986. The criteria were modified by von den Driesch \[[@B5]\] in 1994. According to these criteria, for the diagnosis, two of the major criteria and two of the minor criteria should be fulfilled ([Table 1](#T1){ref-type="table"}). In our patient one major criterion, that abrupt onset of tender erythematous nodules and three minor criteria (associated upper respiratory infection, pathologic laboratory findings, and immediate response to systemic corticosteroids therapy) were fulfilled. The remaining major criterion is histopathologically dense infiltrate of mature neutrophils in the dermis. This case showed histiocytic infiltration with papillary edema instead of the typical neutrophil infiltration in the dermis. Therefore, we conclude that our patient had histiocytoid Sweet\'s syndrome, which was first described by Requena et al. \[[@B3]\] in 2005. Requena et al. \[[@B3]\] studied 42 cases of Sweet\'s syndrome, which were histopathologically characterized by an inflammatory infiltrate composed mostly of histiocytoid mononuclear cells. Based on the immunophenotype, they named this variant \'histiocytoid Sweet\'s syndrome\'. According to the article, the apparent histiocytic mononuclear cells were in fact immature myeloid cells. Probably these lesions result from the release of immature myeloid cells from the bone marrow in the early acute stages of the disease, and these immature myeloid cells are replaced by more mature neutrophilic granulocytes in the later stages of the disease\'s evolution. The presence of the histiocytelike immature myeloid cells does not alter the biological behavior or prognosis of the disease. It is really a histological diagnosis. In general, the lesions follow a benign course, responding promptly to low doses of oral corticosteroids or nonsteroidal anti-inflammatory drugs.

Other conditions to be distinguished from Sweet\'s syndrome are erythema multiforme, Behcet\'s disease, drug eruption, periarteritis nodosa and infectious disorders such as bacterial sepsis, cellulitis, and lymphangitis \[[@B7]\]. Furthermore, Sweet\'s syndrome is an important differential diagnosis to postscald infections \[[@B8]\].

Systemic corticosteroids are the gold standard of therapy for Sweet\'s syndrome. They provide prompt relief of cutaneous and systemic symptoms. Systemic corticosteroid therapy begins with 0.5 to 1.5 mg/kg of body weight per day. Gradual reduction is recommended within 2 to 4 weeks \[[@B5]\].

In our patient, initially tender swelling was seen in the right cheek, such that parotitis was suspected. However, as additional skin lesions appeared, it turned out to be Sweet\'s syndrome. In conclusion, Sweet\'s syndrome should be considered in patients with therapy refractory unclear infiltrated nodules and tender swelling, especially in the face and associated with infection and fever.
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![Case\
Painful swelling on the right cheek.](aps-39-59-g001){#F1}

![Sialography\
Non-obstructive finding of the right parotid duct by sialography.](aps-39-59-g002){#F2}

![Postoperative follow-up\
(A) Erythematous macules on both periocular areas. (B) Erythematous papules and plaques on the dorsa of both hands.](aps-39-59-g003){#F3}

![Histopathologic finding\
Superficial perivenular histiocytic infiltration and nuclear debris admixed with papillary edema (H&E, ×100).](aps-39-59-g004){#F4}

###### 

Diagnostic criteria for classical Sweet\'s syndrome

![](aps-39-59-i001)

From von den Driesch P. J Am Acad Dermatol 1994;31:535-56, with permission from Elsevier \[[@B5]\].

ESR, erythrocyte sedimentation rate.
